Palisade Bio (PALI) Enterprise Value (2016 - 2025)
Palisade Bio (PALI) has disclosed Enterprise Value for 16 consecutive years, with -$5.2 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value rose 34.99% to -$5.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.2 million, a 34.99% increase, with the full-year FY2024 number at -$9.8 million, up 21.0% from a year prior.
- Enterprise Value was -$5.2 million for Q3 2025 at Palisade Bio, up from -$5.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$615000.0 in Q1 2021 to a low of -$16.4 million in Q2 2023.
- A 5-year average of -$10.1 million and a median of -$11.3 million in 2024 define the central range for Enterprise Value.
- Biggest YoY gain for Enterprise Value was 93.87% in 2021; the steepest drop was 1778.03% in 2021.
- Palisade Bio's Enterprise Value stood at -$14.1 million in 2021, then rose by 12.2% to -$12.4 million in 2022, then fell by 0.4% to -$12.4 million in 2023, then grew by 21.0% to -$9.8 million in 2024, then soared by 46.78% to -$5.2 million in 2025.
- Per Business Quant, the three most recent readings for PALI's Enterprise Value are -$5.2 million (Q3 2025), -$5.4 million (Q2 2025), and -$7.2 million (Q1 2025).